EPIRUS Biopharmaceuticals Inc (EPRSQ)
0.00
USD |
OTCM |
Apr 23, 16:00
EPIRUS Biopharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2016 | 0.5676 |
| December 31, 2015 | 0.4079 |
| September 30, 2015 | 0.2925 |
| June 30, 2015 | 0.2506 |
| March 31, 2015 | 0.0991 |
| December 31, 2014 | 0.2243 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | -0.3174 |
| September 30, 2013 | 0.6727 |
| June 30, 2013 | 0.7252 |
| March 31, 2013 | 0.5781 |
| December 31, 2012 | 0.4867 |
| September 30, 2012 | 0.4254 |
| June 30, 2012 | 0.4557 |
| March 31, 2012 | 0.406 |
| December 31, 2011 | 0.4357 |
| September 30, 2011 | 0.2041 |
| June 30, 2011 | 0.1776 |
| March 31, 2011 | 0.0411 |
| December 31, 2010 | 0.0444 |
| Date | Value |
|---|---|
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 2.541 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | 0.8398 |
| June 30, 2008 | 0.4886 |
| March 31, 2008 | 0.3657 |
| December 31, 2007 | 0.2913 |
| September 30, 2007 | 0.409 |
| June 30, 2007 | 0.3225 |
| March 31, 2007 | 0.2109 |
| December 31, 2006 | 0.1571 |
| September 30, 2006 | 0.1355 |
| June 30, 2006 | 0.1295 |
| March 31, 2006 | 0.0727 |
| December 31, 2005 | 0.1057 |
| September 30, 2005 | -0.0789 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 61.34M |
| Total Liabilities (Quarterly) | 35.18M |
| Shareholders Equity (Quarterly) | 26.17M |